Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anja Pfaff, PhD
InflaRx GmbH
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
76 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Clinical Site
Leuven, Belgium
- Clinical Site
Liège, Belgium
- Clinical Site
Hradec Králové, Czechia
- Clinical Site
Prague, Czechia
- Clinical Site
Prague, Czechia
- Clinical Site
Prague, Czechia
- Clinical Site
Angers, France
- Clinical Site
Brest, France
- Clinical Site
Créteil, France
- Clinical Site
Grenoble, France
- Clinical Site
Lille, France
- Clinical Site
Montpellier, France
- Clinical Site
Paris, France
- Clinical Site
Paris, France
- Clinical Site
Paris, France
- Clinical Site
Pessac, France
- Clinical Site
Poitiers, France
- Clinical Site
Jena, Thuringia, Germany
- Clinical Site
Aachen, Germany
- Clinical Site
Berlin, Germany
- Clinical Site
Cologne, Germany
- Clinical Site
Dresden, Germany
- Clinical Site
Essen, Germany
- Clinical Site
Freiburg im Breisgau, Germany
- Clinical Site
Hanover, Germany
- Clinical Site
Kirchheim unter Teck, Germany
- Clinical Site
Leipzig, Germany
- Clinical Site
Ludwigshafen, Germany
- Clinical Site
Mannheim, Germany
- Clinical Site
Münster, Germany
- Clinical Site
Stuttgart, Germany
- Clinical Site
Catania, Italy
- Clinical Site
Lecco, Italy
- Clinical Site
Messina, Italy
- Clinical Site
Milan, Italy
- Clinical Site
Milan, Italy
- Clinical Site
Monza, Italy
- Clinical Site
Pavia, Italy
- Clinical Site
Pisa, Italy
- Clinical Site
Verona, Italy
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Apr 2019
- Primary completion
- 14 Apr 2021
- Completion
- 8 Jun 2021
- Last update posted
- 25 Aug 2022
- Registered enrollment
- 57
- Registry id
- NCT03895801
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.